| 12457550 |
System, method, and computer program for managing a quality of 5G network slice services |
Ashley Lewis Woods, Mark Pond, Luke PARKER |
2025-10-28 |
|
| 8202858 |
Vasopressin V1a antagonists |
Andrzej Roman Batt, Martin Lee Stockley, Michael Bryan Roe, Celine Marguerite Simone Heeney, Peter Hudson +1 more |
2012-06-19 |
|
| 7662825 |
N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
Timothy Johnson, Nicholas Kindon, Bryan Roberts, Michael Stocks |
2010-02-16 |
$9,612,000 |
| 7498338 |
Compounds |
Nafizal Hossain, Svetlana Ivanova, Marguerite Mensonides-Harsema, Austen Pimm, James Thomas Reuberson |
2009-03-03 |
$6,549,000 |
| 7410972 |
Compounds |
Timothy Johnson, Nicholas Kindon, Bryan Roberts, John Steele, Michael Stocks +1 more |
2008-08-12 |
$10,343,000 |
| 7407949 |
Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
Peter Hudson, Andrzej Roman Batt, Celine Marguerite Simone Heeney, Michael Bryan Roe, Peter Andrew Robson |
2008-08-05 |
|
| 7358376 |
Substituted Thiophene compounds |
Stephen Brough, Alan Faull, Craig Johnstone, Thomas McInally |
2008-04-15 |
$7,679,000 |
| 6946478 |
Compounds |
Stephen Brough, Nicholas Kindon, Thomas McInally, Bryan Roberts, Stephen Thom |
2005-09-20 |
$9,554,000 |
| 6903085 |
Substituted piperidine compounds useful as modulators of chemokine receptor activity |
Stephen Thom, Nicholas Kindor, Thomas McInally, Brian Springthorpe, Matthew Perry +3 more |
2005-06-07 |
$11,041,000 |
| 6812226 |
P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disease |
Nicholas Kindon, Garry Pairaudeau, Bryan Roberts, Stephen Thom |
2004-11-02 |
$15,469,000 |
| 6806273 |
Compounds |
Rupert Austin, Roger Bonnert, Fraser Hunt, Elizabeth Kinchin, Paul Willis |
2004-10-19 |
$7,254,000 |
| 6566376 |
Diphenyl-piperidine derivative |
Stephen Brough, Thomas McInally |
2003-05-20 |
$19,016,000 |
| 6562825 |
Piperazine derivatives as modulators of chemokine receptor activity |
Stephen Brough, Nicholas Kindon, Thomas McInally, Bryan Roberts |
2003-05-13 |
$20,152,000 |
| 6518286 |
Compounds |
Stephen Brough, Nicholas Kindon, Thomas McInally, Bryan Roberts, Stephen Thom |
2003-02-11 |
$5,073,000 |
| 6303659 |
Compounds |
Thomas McInally, Michael Mortimore, David Cladingboel |
2001-10-16 |
$8,674,000 |
| 6258838 |
Compounds |
Thomas McInally, Michael Mortimore, David Cladingboel |
2001-07-10 |
$4,685,000 |
| 6242470 |
Adamantane derivatives |
Stephen Brough, Thomas McInally, Michael Mortimore |
2001-06-05 |
$17,392,000 |
| 6201024 |
Adamantane derivatives |
Thomas McInally, Michael Mortimore, David Cladingboel |
2001-03-13 |
$9,578,000 |
| 5348978 |
Angiotensin converting enzyme inhibitors |
Premji Meghani |
1994-09-20 |
$60,000 |
| 4686217 |
Calcium antagonist 2-fluoroalkyl-1,4-dihydropyridines |
John Dixon, Kenneth J. Gould, Alan Tinker |
1987-08-11 |
$425,000 |
| 4607041 |
Antihypertensive 2-phenyl Hantzsch dihydropyridines |
John Dixon, Thomas McInally, Alan Tinker |
1986-08-19 |
$69,000 |
| 4410548 |
Propanolamine derivatives |
Malcolm Myers |
1983-10-18 |
|
| 4401595 |
4-Allyl azetidinone intermediate for .beta.-lactam antibacterial agents |
Patricia M. Roberts, Robert Southgate |
1983-08-30 |
|
| 4323569 |
.beta.-Lactam anti-bacterial, compositions containing them and a process for their preparation |
— |
1982-04-06 |
|
| 4293501 |
.beta.-Lactam antibiotics, a process for their preparation and their use in pharmaceutical compositions |
Roger J. Ponsford, Robert Southgate |
1981-10-06 |
|
